-January 23, 2008
According to the Mesothelioma Applied Research Foundation, better treatments for mesothelioma are within our reach.
The positive predictions come in light of the fact the FDA recently approved Alimta, which is the first FDA approved drug that shows great potential for helping those with mesothelioma.
Meso Foundation Funds Studies
Since the approval of Alimta, the Meso Foundation has developed two studies that hope to further the effectiveness and success of the medication.
New genomic and proteomic technologies are also reportedly allowing researchers to better understand the molecular biology behind meso.
Anti-Agiogenesis
Anti-angiogenesis has also been generating a lot of hope among researchers regarding cancer treatment.
Many scientists believe that meso will be especially vulnerable to this method.
Researchers Work Hard For a Cure
Researchers for the Meso Foundation have reportedly been funded to investigate novel therapeutics, develop new diagnostics and gather an overall better understanding of the mechanisms of tumor formation.
According to reports, competition for Meso Foundation funds is highly intense and these researchers represent some of the top in cancer biology and radiology.
(Source: Advocacy and Awareness)
Do you know someone living with mesothelioma? If so, please contact us to speak with someone about the resources available to you.